PrimeRFP SCOUT · Federal Contract Recompete Brief

36E79723N0003Omeprazole 20mg ORDER WITH GOLDEN STATE — Golden State Medical Supply, Inc

PoP ended Dec 30, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nac Pharmaceuticals (36E797)

Awarding office

Golden State Medical Supply, Inc

Recipient

Dec 30, 2022

PoP end

$430K

Obligated

$430K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36E79723N0003

Also listed as36E797-23-N-0003

Also listed as36E79720D0014-36E79723N0003

AgencyNac Pharmaceuticals (36E797)

Awarding officeNac Pharmaceuticals (36E797)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentGolden State Medical Supply, Inc

CAGE1HT23

UEIGQLDJJ8AQNN5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36E79720D0014

Place of performanceCAMARILLO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 18, 2022

PoP end (current)Dec 30, 2022

Obligated$430K

Current value$430K

Potential value$430K

OMEPRAZOLE 20MG ORDER WITH GOLDEN STATE MEDICAL SUPPLY is a federal award for Nac Pharmaceuticals (36E797) held by Golden State Medical Supply, Inc. Estimated value $430K ($430K obligated). Current period of performance ends Dec 30, 2022. Place of performance: CAMARILLO CA.

OMEPRAZOLE 20MG ORDER WITH GOLDEN STATE MEDICAL SUPPLY

Recompete timing

Public

● Past PoP end (1370 days ago)

Current PoP ended Dec 30, 2022 (1370 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 36E79723N0003? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36E79723N0003?

36E79723N0003 (Omeprazole 20mg ORDER WITH GOLDEN STATE) is a Nac Pharmaceuticals (36E797) award with a potential value of $430K, currently held by Golden State Medical Supply, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36E797-23-N-0003?

36E797-23-N-0003 is the dashed form of PIID 36E79723N0003 (Omeprazole 20mg ORDER WITH GOLDEN STATE), held by Golden State Medical Supply, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36E79723N0003?

Nac Pharmaceuticals (36E797) awarded 36E79723N0003 to Golden State Medical Supply, Inc (potential $430K).

Who is the incumbent on 36E79723N0003?

Golden State Medical Supply, Inc is the incumbent. The current period of performance ends Dec 30, 2022.

When does Golden State Medical Supply, Inc’s 36E79723N0003 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36E79723N0003? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Dec 13, 2022 · refreshed monthly